realize the potential of Metabolic Medicine

KGK Synergize
Lab Tests on Cell Lines

 

Oncology Outcome Studies
Oncologist 1,000 Patient/Stage IV Study

Published Articles
Poly-MVA / Lipoic Acid Complex articles on Pubmed.com

Poly-MVA Inventor Papers
     Dr. Merrill Garnett

Metabolic Cancer Therapies

Put simply, cancer cells have aberrant energy metabolism compared to normal cells. Metabolic Cancer therapies attempt to exploit this difference. Cancer cells have a reduced capacity to generate energy with oxygen (oxidative energy production), with a concurrent increase in energy generation without oxygen. On Average a healthy cell produces 89% of its energy using oxygen, and 11% through non-oxidative metabolism (non-oxidative metabolism is also known as “fermentation”). Oxidative energy production is far more efficient than fermentation. Almost 20 times more energy is released when glucose is completely oxidized, as opposed to when it is fermented.

 

Healthy Mitochondria. Note the abundant looping structures inside the mitochondria (cristae), this is where all energy is produced through oxidative pathways.

Image of a mitochondria from a cancer cell. Note the almost compete absence of cristae.

PET scan showing widespread metastasisOxidative energy production takes place in a cellular organelle called the mitochondria. The mitochondria are known as the cellular “power plants.” Also telling is the fact that the greater the degree of fermentation displayed by a given cancer, the more aggressive the cancer. Because a tumor cell’s mitochondria appear to be dis-regulated, and generate energy by such an inefficient pathway, they have to consume much more glucose to remain viable. A glance at a PET scan, which uses a radioactive labeled glucose analog to image cancer, provides stunning visual evidence of the voracious appetite tumor cells have for glucose compared to normal tissue.

Altered Metabolism May be One of the Drivers of Cancer

It is well established that once a cell  has an impaired ability to produce energy through oxidative pathways, the genomic instability (increased potential for DNA mutations to occur) that accompanies tumor development, inevitable follows.  While it’s true that most of the agents known to cause cancer; chemical carcinogens, viruses, radiation, and inflammation can cause mutations to DNA, it is also true these provocative agents damage the mitochondria. The metabolic theory of cancer states that once the mitochondria of a given cell become disregulated, and the cell reverts to fermentation to obtain energy, a plethora of metabolic and epigenetic modifications participate in the origin of cancer.

 

Progressionofcancer

 

Poly-MVA Research, Science and Studies

Poly MVA Laboratory

Lung Cancer Study

Low Dose Chemo Report

Stage 4 Oncology Studies

Frank Antonowich PhD
READ REPORT

Published Scientific Study
READ REPORT

Oncology Study Overview
READ REPORT

James W. Forysythe, M.D. H.M.D.
READ REPORT
 

Poly-MVA Articles

Cancer Tutor

Naturopathic Medicine

Cancer-Stroke-Anti-Aging

Cancer-Stroke-Anti-Aging

In 2007, KGK Science, Inc., an independent laboratory in Canada, examined the effects of POLY-MVA on 8 cancer cell lines.

These lines included:
1) Skin melanoma, human (SKMel-5)
2) Liver, hepatocellular carcinoma, human (Hep G2)
3) Lung, malignant melanoma, human (Malme-3M)
4) Mammary gland, ductal carcinoma, human (MDA-MB 435)
5) Prostate, left supraclavicular lymph node carcinoma, human (LNCaP)
6) Colon, colorectal adenocarcinoma, human (HT-29)
7) Human brain, glioblastoma; astrocytoma (U87)
8) Glioblastoma (HT-80)

POLY-MVA was administered at 3 different dosages and the number of cells was examined after 24, 48 and 72 hours following initial application. POLY-MVA was effective, to varying degrees, on the entire group of cell lines tested (melanoma, liver, lung, breast, prostate, colon, astrocytoma and glioblastoma).

The varying effectiveness appears to be a consequence of the particular cell lines used and their associated degree of anaplasia.

The graph above demonstrates the benefit of POLY-MVA after 48 hours of initial exposure: The Y-axis represents the number of cells per mL.

Poly MVA causes significant cell death after 48 Hours of exposure 
per mL.  SHAPE  \* MERGEFORMAT CPM
The table below illustrates the statistically significant level of cell death
(p must be equal to or less than 0.05) induced by POLY-MVA after 48 hours of initial exposure: 

Garnett McKeen In vitro Cancer Assays:
Garnett McKeen Laboratory Inc. (GML) chose to mimic the National Cancer Institute’s (NCI) cell screening protocol.

The following cell lines were selected from the NCI repository:
MCF-7 (breast adenocarcinoma), and A549 (lung non-small cell adenocarcinoma).

The data below represents the completion of the Breast Cancer (MCF-7), Ovarian Cancer (OVCAR-5) and Lung Carcinoma (A549) assay.

We have also completed assays using stage IV glioblastoma multiforme (H-80) and astrocytoma (H-4) brain tumor lines.

As noted below, all of the studies demonstrated significant cell death.

Dual Poly-MVA bottle

CANCER CELL DEATH RATE IN 5 CELL LINES

After 48 hours of exposure

Scroll to Top